The Full Wiki

More info on Ranimustine

Ranimustine: Wikis

Advertisements
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Ranimustine
Systematic (IUPAC) name
methyl 6-({[(2-chloroethyl)(nitroso)amino]carbonyl}amino)-6-deoxy-α- D-glucopyranoside
Identifiers
CAS number 58994-96-0
ATC code L01AD07
PubChem 71741
Chemical data
Formula C 10H18ClN3O7  
Mol. mass 327.71 g/mol
SMILES eMolecules & PubChem
Synonyms 1-(2-chloroethyl)-1-nitroso-3-([(2R,3S,4 S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl)urea
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status Prescription only
Routes IV

Ranimustine (INN, marketed under the tradename Cymerin; also known as MCNU) is a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia[1] and polycythemia vera.[2]

It has never been filed for FDA evaluation in the United States, where it is not marketed.

References

  1. ^ Kitajima K, Adachi T, Takahashi I, et al. (November 1989). "[Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis]" (in Japanese). Gan To Kagaku Ryoho 16 (11): 3573–9. PMID 2817908.  
  2. ^ Nagai M, Tasaka T, Kamano H, et al. (December 1988). "[Therapeutic effect of ranimustine (MCNU) on essential thrombocythemia and polycythemia vera]" (in Japanese). Gan To Kagaku Ryoho 15 (12): 3267–70. PMID 3196045.  
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message